[Asia Economy Reporter Lee Junhyung] GeneOne Life Science announced on the 18th that it has signed a supply contract worth 2.5 billion KRW for Plasmid DNA with a US biotech company.


The contract amount is 6% of last year's consolidated sales (41.2 billion KRW).



The contract period is until January 31, 2022. Due to business confidentiality, the contracting party will withhold disclosure until December 18, 2030.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing